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Abstract: The mechanism of altered glucose metabolism seen on positron emission tomography (PET) in focal
epilepsy is not fully understood. We determined the association between interictal glucose metabolism and
interictal neuronal activity, using PET and electrocorticography (ECoG) measures derived from 865 intracra-
nial electrode sites in 11 children with focal epilepsy associated with tuberous sclerosis complex (TSC) (age:
0.5–16 years) undergoing epilepsy surgery. A multiple linear regression analysis was applied to each patient,
to determine whether the glucose uptake at each electrode site on interictal PET was predicted by ECoG ampli-
tude powers and interictal spike-frequency measured in the given electrode site. The regression slopes as well
as R-square values (an indicator of fitness of the regression models) were finally averaged across the 11
patients. The mean regression slope for delta amplitude power was 20.0025 (95% CI: 20.0045 to 20.0004; P5
0.02 based on one-sample t-test) and that for spike frequency was 20.023 (95% CI: 20.042 to 20.0038; P 5
0.02). On the other hand, the mean regression slopes for the remaining ECoG amplitude powers (theta, alpha,
sigma, beta, and gamma activities) were not significantly different from zero. The mean R-square value was
0.39. These results suggest that increased delta-slowing and frequent spike activity were independently and
additively associated with glucose hypometabolism in children with focal epilepsy associated with TSC. Asso-
ciation between frequent interictal spike activity and low glucose metabolism may be attributed to slow-wave
components following spike discharges on ECoG recording, and a substantial proportion of the variance in re-
gional glucose metabolism on PET could be explained by electrophysiological traits derived from conventional
subdural ECoG recording.HumBrainMapp 29:1255–1264, 2008. VC 2007Wiley-Liss, Inc.
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INTRODUCTION
Positron emission tomography (PET) is a noninvasive
functional imaging modality, which measures regional
uptake of radiotracers designed to evaluate metabolism,
blood flow, receptor binding properties, and other physio-
logical processes in the human body, and PET imaging
using 2-deoxy-2-[18F] fluoro-D-glucose (FDG) has been used
to evaluate glucose metabolism patterns of human cerebral
cortex [Chugani and Phelps, 1986; Phelps and Mazziotta,
1985]. Previous PET studies of patients with focal epilepsy
associated with dysplastic lesions have shown that glucose
is quite unevenly utilized in the cerebral cortex; the majority
of dysplastic lesions, such as focal cortical dysplasia and
cortical tubers, are hypometabolic on interictal FDG PET
[Chugani et al., 1990; Kim et al., 2000; Rintahaka and Chu-
gani, 1997; Szelies et al., 1983] and, in some cases, removal
of the hypometabolic cortex associated with EEG abnormal-
ities have resulted in good surgical outcomes [Chugani
et al., 1990; Kim et al., 2000]. On the other hand, it has also
been reported that the presumed epileptogenic focus can be
hypermetabolic [Chugani et al., 1993; Engel et al., 1982] or
normo-metabolic [Juhász et al., 2000] on interictal FDG PET
in a substantial proportion of patients with focal epilepsy.
Currently, no quantitative relationship has been demon-
strated between the degree of glucose metabolism and the
frequency of interictal spikes on scalp EEG [Engel et al.,
1982; Lucignani et al., 1996], but a negative correlation
between glucose metabolism in the lateral temporal cortex
and its regional delta slowing on scalp EEG has been
reported in adults with temporal lobe epilepsy [Erbayat
Altay et al., 2005; Koutroumanidis et al., 1998].
Do electrophysiological traits other than delta slowing
explain the variance of cortical glucose metabolism in indi-
viduals with focal epilepsy? We hypothesized that the fast-
wave electrocorticography (ECoG) components derived from
physiological and pathological neuronal activities were asso-
ciated with high glucose metabolism, whereas slow-wave
components were associated with decreased glucose metabo-
lism in patients with focal epilepsy. In the present study of
11 children with focal epilepsy associated with tuberous
sclerosis complex (TSC), we determined whether interictal
subdural ECoG measures fitted into multiple regression
equations could explain the variance of regional glucose me-
tabolism on interictal FDG PET. We chose TSC as a model
to study the relationship between glucose hypometabolism
and ECoG traits, since TSC is an autosomal-dominant disor-
der characterized by cortical tubers, which are known to be
stable in size over time, not preferentially localized to a
certain location, and appear hypometabolic on FDG PET
[Huttenlocher and Heydemann, 1984; Machado-Salas, 1984;
Roach et al., 1998; Szelies et al., 1983].
METHODS
Patients
The inclusion criteria of the present study included: (i)
age ranging from 5 months to 17 years, (ii) a diagnosis of
uncontrolled focal seizures associated with TSC [Roach
et al., 1998], (iii) a two-stage epilepsy surgery using extra-
operative ECoG monitoring in Children’s Hospital of Michi-
gan, Detroit between May 2002 and October 2005, and (iv)
2-deoxy-2-[18F] FDG PET performed within 12 months prior
to the implantation of subdural electrodes. The exclusion cri-
teria included history of previous epilepsy surgery. We stud-
ied a consecutive series of 11 children (age: 5 months–16
years; 5 girls and 6 boys) who met the inclusion criteria and
satisfied the exclusion criteria (Table I). All 11 children
underwent scalp video-EEG monitoring, MRI, FDG PET,
and chronic intracranial ECoG monitoring with subdural
electrodes as part of their pre-surgical evaluation. The study
has been approved by the Institutional Review Board at
Wayne State University, and written informed consent was
obtained from the parents or guardians of all subjects.
MRI Procedure
MRI studies were performed on a GE Signa 1.5-Tesla
scanner (GE Medical Systems, Milwaukee, WI) before sub-








Location of interictal spikes on
scalp EEG during FDG PET
Interval between PET and
ECoG measurements (months)
1 0 year 5 months M Awake Rt-C-P-T, Lt-C-P-T 2
2 1 year 2 months M Awake Lt-C-F-T, Rt-P, Lt-P 4
3 1 year 6 months M Awake and sleep Lt-C-P-T, Lt-F-T 3
4 1 year 11 months F Sleep Rt-F-C, Rt-T, Rt-P, Lt-F-C 6
5 3 years 1 month F Awake None 2
6 3 years 3 months F Awake Lt-O, Lt-F, Lt-P-T, Lt-F-C-T, Rt-P-T 3
7 5 years 3 months M Sleep Lt-T 9
8 6 years 7 months M Awake Rt-T-O, Rt-O 6
9 7 years 5 months F Awake Lt-P 9
10 9 years 9 months F Awake Lt-O 12
11 16 years 0 month M Awake None 3
y, year; mo, month; F, female; M, male; F, frontal; C, central; P, parietal; O, occipital; T, temporal.
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dural electrode placement, as previously described [Juhász
et al., 2000]. Anatomical/volumetric imaging of the whole
brain was performed in all patients utilizing a T1-weighted
spoiled gradient echo (SPGR) sequence. The 3D SPGR
sequence [repetition time (TR) 35 ms; echo time (TE) 5 ms;
flip angle, 358; slice thickness, 1.5 mm; field of view 240
mm] was acquired in the coronal plane.
PET Procedure
FDG PET studies were performed using the CTI/Siemens
Exact/HR whole-body positron tomograph before Subdural
electrode placement, as previously described [Juhász et al.,
2000; Muzik et al., 1998]. In short, this scanner generates 47
image planes with a slice thickness of 3.125 mm, and the
reconstructed image in-plane resolution obtained was 5.5 6
0.35 mm full widths at half-maximum. Following a 40-min
uptake period after the injection of FDG, a 20-min static
scan was acquired. The scalp EEG was monitored through-
out the uptake period to verify that all scans were interictal.
Subsequently, we determined the state change (awake or
sleep) of the patient during the first 20 min after FDG
administration (Table I). None of the patients had seizures
within 2 h before PET tracer injection or a secondarily gener-
alized tonic clonic seizure within 8 h before PET tracer injec-
tion. The mean interval between PET scanning and subdural
electrode placement was 5.4 months (range: 2–12 months).
Subdural Electrode Placement
For chronic intracranial ECoG recording, platinum grid
electrodes (10 mm intercontact distance, 4 mm diameter;
Ad-tech, Racine, WI) were surgically implanted as previ-
ously described [Asano et al., 2005]. Depth electrodes were
also implanted as needed. The placement of intracranial
electrodes was guided by the results of scalp video-EEG
recording, MRI, interictal glucose metabolism on FDG
PET, and interictal alpha-[11C] methyl-L-tryptophan PET
[Kagawa et al., 2005]. All electrode plates were stitched to
adjacent plates and/or the edge of dura mater, to avoid
movement of subdural electrodes after placement. In addi-
tion, intraoperative pictures were taken with a digital cam-
era before dural closure to confirm the spatial accuracy of
electrode display on three-dimensional brain surface recon-
structed from MRI [Asano et al., 2005].
Extraoperative Video-ECoG Recording
Extraoperative video-ECoG recordings were performed
as previously described [Asano et al., 2003, 2007]. Anti-epi-
leptic medications were discontinued or reduced during
ECoG monitoring until a sufficient number of habitual
seizures (typically three seizures) were captured. A ground
lead and a reference electrode were placed to the contralat-
eral mastoid by a registered EEG technician. Surface EMG
recordings from the left and right deltoid muscles were
added as needed. ECoG data were obtained using a Stel-
late HARMONIE digital system [sampling rate: 200 Hz;
Stellate, Quebec, Canada] for 3–5 days. Clinical manifesta-
tions were assessed using synchronized digital videos with
30 frames per second. Interictal epileptiform discharges
[Asano et al., 2003], ictal discharges [Lee et al., 2000] and
state changes [Asano et al., 2007] were visually assessed
with a low-frequency filter of 0.5–1 Hz and high-frequency
filter of 35–100 Hz. A low frequency filter of 3.0 Hz or
higher was occasionally used to assess a low-amplitude
fast wave activity.
Coregistration of PET, MRI, and Subdural
Electrodes
Before subdural electrode placement, FDG PET, and
MRI SPGR image volumes were coregistered as described
previously [Juhász et al., 2000; Muzik, 1998; Pietrzyk et al.,
1994], using MPI-Tool (Max-Planck-Institute, Cologne,
Germany), which is a software package employing a multi-
purpose 3D registration technique. Following subdural
electrode placement, planar X-ray images (lateral and ante-
rior–posterior images) were acquired for determining the
location of the electrodes on the brain surface. Three me-
tallic fiducial markers were placed at anatomically well-
defined locations on the patient’s head for coregistration of
the X-ray with the MRI as previously described [Juhász
et al., 2000; von Stockhausen et al., 1997].
To reconstruct surface views corresponding to the planar
X-ray image, three virtual markers were defined in the
SPGR MR image volume at the same position as in the
planar X-ray image, as previously described [Juhász et al.,
2000; Muzik et al., 1998; von Stockhausen et al., 1997].
Using the software package ‘‘3D Tool’’ (Max-Planck-Insti-
tute, Cologne, Germany), a surface view was created,
which corresponds to the planar X-ray image position, and
where the location of electrodes was directly defined on
the brain surface. The accuracy of this procedure was
reported previously as 1.24 6 0.66 mm with a maximal
misregistration of 2.7 mm [von Stockhausen et al., 1997)
and was confirmed by intraoperative digital photographs
showing in situ locations of the subdural electrodes [Asano
et al., 2005]. Anatomical landmarks (central sulcus, Sylvian
fissure, and gyral pattern) that were readily identifiable on
both the photographs and the 3D-reconstructed brain sur-
face were used to verify the exact location of the electro-
des. Following coregistration of the subdural grid with the
surface view, virtual spheres were created at those loca-
tions on the brain surface to represent a projection of the
electrodes onto the surface. These spheres mark the posi-
tion of the electrodes on the cortical surface and allow the
assessment of intracranial electrode location relative to the
MRI and FDG PET metabolism from varying view angles.
Ranking Cortical Glucose Metabolism on Each
Subdural Electrode Site
Glucose metabolism values were rescaled into six frac-
tional units (ranks) with equal range as follows: 0.0
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(lowest), 0.2, 0.4, 0.6, 0.8, and 1.0 (highest), using the soft-
ware package ‘‘3D Tool.’’ Subsequently, rescaled PET me-
tabolism was delineated with different colors on each indi-
vidual 3D-brain surface image (supplementary Fig. S1).
Each subdural electrode site was assigned a PET fractional
rank shown earlier, according to the color scale within the
brain immediately below each electrode seen on the 3D-
brain surface image. A subdural electrode located on a
boundary between distinct PET colors was given a PET
fractional rank, based on the larger size of PET color under
the electrode. This method allows more rapid estimation
of cortical glucose metabolism, compared with an alterna-
tive method of computation of glucose metabolism by
drawing regions of interest in each cortical area as per-
formed in previous studies [Asano et al., 2000; Kagawa
et al., 2005].
Quantitative Measurement of Interictal ECoG
Amplitude Powers
ECoG amplitude powers for each subdural electrode site
were quantitatively measured using a method similar to
that reported in previous ECoG studies [Asano et al., 2004,
2005; Gotman et al., 1993]. subdural electrodes showing
artifacts [Klem, 2003], depth electrodes, epidural electro-
des, electrodes overlying another electrode array, and elec-
trodes facing the presumed nonepileptic hemisphere via
the falx were excluded from further analysis, and a total of
865 subdural electrodes (48–99 electrodes per subject) were
analyzed. The quantitative ECoG analysis was performed
using the Stellate SENSA software [Asano et al., 2003,
2007; Gotman et al., 1993].
First, ECoG signals were remontaged to an average ref-
erence, to obtain reference-free topographic maps of spec-
tral measures [Crone et al., 1998]. A 10-min ECoG segment
during quiet wakefulness and another segment during
sleep were selected from the interictal extraoperative
ECoG data, based on the following criteria: at least 8 h
after a secondarily generalized tonic clonic seizure and at
least 2 h after other types of clinical seizures [Asano et al.,
2005, 2007]. A consecutive series of 5.12-s epochs were
placed over the 10-min awake ECoG segment as well as
the 10-min sleep segment. After the placement of consecu-
tive epochs, an amplitude spectrum (x-axis unit: Hz; y-axis
unit: lV/Hz) was created for each epoch and each chan-
nel, using a Fast Fourier Transformation. The software
Subsequently displayed the ECoG amplitude power (unit:
lV) at each epoch within preset frequency bands, which
was calculated as the summation of all frequency compo-
nents under the amplitude spectral curve within the given
frequency band. The frequency bands were preset as fol-
lows: 0.5–4.0 Hz (delta band), 4.0–8.0 Hz (theta band), 8.0–
12.0 Hz (alpha band), 12–16 Hz (sigma band), 16–32 Hz
(beta band), 32–64 Hz (low-frequency gamma band), and
64–100 Hz (high-frequency gamma band) [Asano et al.,
2005]. The ECoG amplitude power of 32–64 Hz was calcu-
lated without a 56–64 Hz component, if visual inspection
revealed a 60 Hz artifact peak on the amplitude spectral
curve for all subdural electrodes [Asano et al., 2004]. Sub-
sequently, ECoG amplitude powers for the earlier-men-
tioned frequency bands were averaged across the whole
awake epochs and separately averaged across the whole
sleep epochs. This procedure finally yielded the mean
ECoG amplitude powers for (i) ‘‘delta,’’ (ii) ‘‘theta,’’ (iii)
‘‘alpha,’’ (iv) ‘‘sigma,’’ (v) ‘‘beta,’’ (vi) ‘‘low-frequency
gamma,’’ and (vii) ‘‘high-frequency gamma’’ bands, for
each electrode site, and for each state (Fig. 1 and supple-
mentary Figs. S2 and S3).
Quantitative Analysis of Spike Frequency
Recorded on ECoG
Quantitative analysis of interictal spike frequency was
performed on the ECoG, using Stellate SENSA software
[Asano et al., 2003, 2007; Gotman and Gloor, 1976]. The
same 10-min awake and sleep segments used in the power
amplitude analysis were utilized for spike frequency anal-
ysis. It has been reported that the spatial distribution of
interictal spike frequency is similar between 10-min awake
and sleep ECoG segments in children with focal epilepsy
[Asano et al., 2007]. Each electrode site was given a spike
frequency measure during wakefulness as well as that dur-
ing sleep (Fig. 1 and supplementary Figs. S2 and S3).
Delineation of ECoG Data on
3D-Reconstructed MRI
Quantitative measures including ECoG amplitude
powers as well as interictal spike frequency were
delineated on each individual 3D-reconstructed MRI
(Fig. 1 and supplementary Figs. S2 and S3) as previously
described [Asano et al., 2005]. Electrode positions (x- and
y-axis values) on the planar X-ray coordinate were meas-
ured for every electrode using Microsoft PowerPoint
(Microsoft, Redmond, WA), and were registered into the
SurGe Interpolation Software (Web site: http://mujweb.
cz/www/SurGe/surgemain.htm). The topographic map
derived from the skull X-ray images was used to display
the earlier-mentioned ECoG measures on the 3D-recon-
structed surface image.
Statistical Analysis
A multiple linear regression model was applied to each
individual patient to predict the PET fractional rank (a
measure of glucose uptake) in each electrode site using
ECoG measures in the given electrode site. Thereby, the
outcome measure was the PET fractional rank and treated
as a continuous variable. ECoG measures as predictors
included (i) ‘‘delta amplitude power,’’ (ii) ‘‘theta amplitude
power,’’ (iii) ‘‘alpha amplitude power,’’ (iv) ‘‘sigma ampli-
tude power,’’ (v) ‘‘beta amplitude power,’’ (vi) ‘‘low-fre-
quency gamma amplitude power,’’ (vii) ‘‘high-frequency
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gamma amplitude power,’’ and (viii) ‘‘interictal spike fre-
quency.’’
ECoG measures during wakefulness were utilized in 8
patients (Nos. 1, 2, 6, 7, 9, 10, 11, and 12) who were awake
during the first 20-min PET uptake period, whereas ECoG
measures during sleep were utilized in 2 patients (Nos. 5
and 8) who were asleep during PET uptake period. In
patient No. 3, who was awake for the first 8 min and
asleep for the subsequent 12 min during the PET uptake
period, weighted-average ECoG measures (40% from
awake segments and 60% from sleep) were utilized. This
approach was taken, since a previous study showed that
glucose PET pattern during awake state differed from that
during sleep in normal controls [Buchsbaum et al., 2001].
A multiple regression model tested in the present study
is shown below.
YPETi ¼ b0i þ bDi 3 XDi þ bTi 3 XTi þ bAi 3 XAi
þ bSi 3 XSi þ bBi 3 XBi þ bLGi 3 XLGi
þ bHGi 3 XHGi þ bSPi 3 XSPi;
where (YPETi) represented the expected PET fractional rank
in a subdural electrode site showing a delta amplitude
power of (XDi), a theta amplitude power of (XTi), an alpha
amplitude power of (XAi), a sigma power of (XSi), a beta
amplitude power of (XBi), a low-frequency gamma ampli-
tude power of (XLGi), a high-frequency gamma amplitude
power of (XHGi), and interictal spike frequency of (XSPi) in
subject i (i 5 1, 2,. . ., and 11). Thereby, subject i was
assigned a regression slope for ‘‘delta amplitude power’’
(bDi), ‘‘that for theta amplitude power’’ (bTi), ‘‘that for
alpha amplitude power’’ (bAi), ‘‘that for sigma amplitude
power’’ (bSi), ‘‘that for beta amplitude power’’ (bBi), ‘‘that
for low-frequency gamma amplitude power’’ (bLGi), ‘‘that
for high-frequency gamma amplitude power’’ (bHGi), and
‘‘that for interictal spike frequency’’ (bSPi). Each regression
model assigned to each subject yielded an R-square value
(an indicator of fitness of the regression models).
Subsequently, the one-sample t-test was applied to the
means of each regression slope. The statistical null hypoth-
esis was that each of the mean regression slopes averaged
among 11 subjects (mean bD, mean bT, mean bA, mean bS,
mean bB, mean bLG, mean bHG, and mean bSP) was zero,
whereas the alternative hypothesis was that each mean
regression slope was different from zero. A significance
level of 0.05 was used, and a 95% confidence interval (95%
CI) was calculated for the mean of each regression slope.
Similarly, the mean R-square value across the 11 subjects
was calculated.
Finally, association between ‘‘the model fitness repre-
sented by an R-square value’’ and ‘‘the PET-ECoG inter-
val’’ was assessed using a linear regression analysis (sup-
plementary Fig. S4), to determine whether a long interval
between PET and ECoG studies was a factor decreasing
Figure 1.
FDG PET and ECoG measures in a 14-month-old boy with
uncontrolled seizures associated with tuberous sclerosis com-
plex. (A) Interictal FDG PET showed nodular glucose hypometa-
bolic regions involving the left temporal, frontal and parietal
regions. (B–I) Topographic map of spectral amplitude power and
interictal spike activity. The largest hypometabolic area in the left
temporal region was associated with increased delta amplitude
power as well as increased spike frequency. (J) Topography of
PET fractional ranks expected from the regression model: YPET
5 0.21 1 0.0012 3 XD 2 0.018 3 XT 1 0.079 3 XA 2 0.18
3 XS 1 0.14 3 XB 2 0.14 3 XLG 1 0.47 3 XHG 2 0.091 3
XSP. The R-square value for this regression model was 0.53.
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the association between PET and ECoG measures. All sta-
tistical analyses were performed using the computer soft-
ware SAS1 9.1 (SAS Institute, Cary, NC).
RESULTS
Individual FDG PET and ECoG data in three cases are
presented in Figure 1 and supplementary Figures S2 and
S3. The range and mean of ECoG measures for all subjects
are presented in supplementary Table SI. Visual assess-
ment revealed that the areas showing glucose hypometab-
olism were larger than those of MRI-visible tubers in all
patients, as previously reported [Asano et al., 2000]. Visual
assessment also revealed that focal delta slowing predomi-
nantly involved the center of glucose-hypometabolic cortex
overlying a cortical tuber, and the degree of delta slowing
appeared less prominent in the periphery of glucose hypo-
metabolic areas. The electrode showing the greatest spike
frequency was located in the center of glucose hypometa-
bolic area in six children (patients nos. 2, 4, 5, 8, 9, and 11)
and located on the margin of glucose hypometablosm in
the remaining five children.
The mean regression slopes as well as the mean R-
square values averaged across the 11 subjects are pre-
sented in Table II. The mean regression slope for delta am-
plitude power (5mean bD) was 20.0025 (95% CI: 20.0045
to 20.0004; P 5 0.02 based on one sample t-test) and that
for spike frequency (5mean bSP) was 20.023 (95% CI:
20.042 to 20.0038; P 5 0.02). These results indicated that
each 1 lV increase in delta amplitude power was associ-
ated with a decrease in a PET fractional rank by 0.0025,
and that each 1 per min increase in spike frequency was
associated with a decrease in a PET fractional rank by
0.023. On the other hand, the mean regression slope for
the remaining ECoG amplitude powers (theta, alpha,
sigma, beta, or gamma activities) were not significantly
different from zero (Table II).
The mean R-square value across the 11 subjects was 0.39
(range: 0.27–0.68); thus, about 40% of the variance of PET
fractional ranks among electrodes were explained by the
multiple linear regression models using the earlier-men-
tioned eight ECoG measures in the given electrode site.
The ‘‘interval between PET and ECoG studies in each
subject’’ and ‘‘the R-square value derived from the regres-
sion model’’ are plotted in supplementary Figure S4. There
was no statistically significant linear association between
‘‘the interval between PET and ECoG studies’’ and ‘‘the R-
square value derived from the regression model’’ (P 5 0.2
based on linear regression analysis).
DISCUSSION
The present study demonstrates that regional glucose
uptake measured by interictal FDG PET was negatively
correlated to delta activity (0.5–4.0 Hz) and interictal spike
frequency recorded in intracranial electrode sites in chil-
dren with focal epilepsy associated with TSC. On the other
hand, the study failed to prove a quantitative linear associ-
ation between regional glucose metabolism and the
remaining ECoG measures (theta, alpha, sigma, beta, or
gamma activities). Independent and additive association
between ‘‘glucose hypometabolism on PET’’ and ‘‘delta
slowing’’ and ‘‘interictal spike frequency on ECoG’’ is a
novel finding in the present study, and the results increase
our understanding of the pathophysiology of altered corti-
cal metabolism in relation to electrophysiology in children
with focal epilepsy associated with dysplastic lesions.
Significance of Delta Slowing in Relation to
Cortical Glucose Metabolism
In the present study, a delta-range amplitude power
value in each electrode site probably consisted of physio-
logical and pathological components. It is well known that
delta slowing is diffusely increased during non-REM sleep
in healthy humans [Nekhorocheff, 1950] and increased
proportion of delta wave activity is one of the criteria for
definition of sleep stages [Erwin et al., 1984; Nekhorocheff,
TABLE II. Mean regression slopes for ECoG measures and mean R-square value for the regression models
Mean among the
11 subjects 95% Cl P-Value
Intercept (bo) 0.57 (0.41, 0.73) <0.001
Regression slope for ‘delta amplitude power’ (bD) 20.0025 (20.0045, 20.0004) 0.02
Regression slope for ‘theta amplitude power’ (bT) 20.0072 (20.017, 0.0025) 0.1
Regression slope for ‘alpha amplitude power’ (bA) 0.0051 (0.021, 0.031) 0.7
Regression slope for ‘sigma amplitude power’ (bS) 0.054 (20.018, 0.13) 0.1
Regression slope for ‘beta amplitude power’ (bB) 20.014 (20.079, 0.051) 0.6
Regression slope for ‘gamma amplitude power’ (bLG) 20.021 (20.081, 0.040) 0.5
Regression slope for ‘gamma amplitude power’ (bHG) 0.044 (20.086, 0.17) 0.5
Regression slope for ‘spike amplitude power’ (bSP) 20.023 (20.042, 20.0038) 0.02
R2Square 0.39 NA NA
The mean regression slope for delta amplitude power as well as that for interictal spike frequency was significantly smaller than zero.
Each P- value was derived from a one sample t-test where the null hypothesis was that the mean regression slope was zero whereas the
alternative hypothesis was that the regression slope was different from zero.
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1950]. Previous studies using [15O]-water PET and scalp
EEG showed that delta wave activity was increased during
non-REM sleep and the magnitude of delta wave activity
was negatively correlated to cerebral blood flow in healthy
volunteers [Dang-Vu et al., 2005; Hofle et al., 1997].
A relationship between pathological delta slowing and
regional glucose hypometabolism has been shown in pre-
vious studies. For example, studies in dogs and rodents
using ECoG recording have demonstrated that delta wave
amplitude is increased on a real-time basis when a re-
gional cerebral lesion is artificially produced by arterial
occlusion or a toxic substance [Carpentier et al., 2001;
Gurvitch and Ginsburg, 1977; Hartings et al., 2006]. Studies
of Alzheimer’s disease [Valladares-Neto et al., 1995] and
vascular dementia [Szelies et al., 1999] patients have found
that the magnitude of delta slowing on scalp EEG was
negatively correlated to cerebral glucose metabolism on
PET. Studies of adults with temporal lobe epilepsy
revealed that the magnitude of delta slowing in the lateral
temporal cortex was negatively correlated to regional glu-
cose metabolism in that area [Erbayat Altay et al., 2005;
Koutroumanidis et al., 1998]. Taken together, delta wave
activity recorded on interictal ECoG may be an indicator
of underlying low neuronal activity.
Significance of Frequent Interictal Spikes in
Relation to Cortical Glucose Metabolism
It is still uncertain whether interictal epileptiform dis-
charges represent excitatory, inhibitory or a combination of
the two. Studies in cats using intracellular electrophysiol-
ogy recording [Contreras et al., 1997; Fisher and Prince,
1977] as well as a study of adults with temporal lobe epi-
lepsy using paired pulse stimulation [Wilson et al., 1998]
suggested that the slow-wave component of interictal
spike-and-wave discharges represented inhibitory postsy-
naptic potentials, which temporarily inactivated cortical
function. A study of adults with focal epilepsy using
ECoG showed that maximum delta activity coincided spa-
tially with or adjacent to the cortical area showing maxi-
mum spiking in 22 out of 40 cases [Panet-Raymond and
Gotman, 1990]. Recent studies using simultaneous record-
ing of functional MRI and scalp EEG showed that interictal
epileptiform discharges were associated with regional
deactivation in the presumed epileptogenic focus and the
surrounding cortex in a subset of patients with focal epi-
lepsy [Federico et al., 2005; Kobayashi et al., 2006], and it
was reported that spike-and-slow waves were always asso-
ciated with deactivation, which was not observed with
spikes not followed by a slow wave [Kobayashi et al.,
2006]. Another study using functional MRI showed that
blood oxygenation level-dependent responses associated
with interictal epileptiform discharges were predominantly
positive in the thalamus and predominantly negative in
the cortex in patients with idiopathic and secondarily gen-
eralized epilepsy [Hamandi et al., 2006]. Association
between glucose hypometabolism and frequent interictal
epileptiform discharges found in the present study might
be attributed to slow-wave EEG components following
spikes.
The association between frequent spiking and glucose
hypometabolism shown in the present study seems to be
inconsistent with the previous observations that many epi-
leptic patients with very frequent interictal spiking activ-
ities [Chugani et al., 1993], continuous spike-and-wave
during slow-wave sleep [Luat et al., 2005] or periodic later-
alized epileptiform discharges [Handforth et al., 1994] had
regional glucose hypermetabolism on FDG PET. Further
studies on epileptic patients with focal hyper- and hypo-
metabolism on PET may determine the electrophysiologi-
cal traits distinctively associated with glucose hypermetab-
olism and hypometabolism in the future.
Causal Relationship Between Interictal Neuronal
Activity and Cortical Glucose Metabolism
The present study was not designed to determine the
causal relationship but association between regional inter-
ictal neuronal activity and cortical glucose metabolism in
children with focal epilepsy with TSC. Thus, it is still
unknown whether interictal neuronal activity ‘‘drives’’ or
‘‘is driven by’’ the metabolism of cortical tissue exerting
this activity. Previous human studies using transcranial
magnetic stimulation have shown that low frequency (1
Hz) stimulation decreases the amplitude of motor-evoked
potentials, indicating decreased excitability [Chen et al.,
1997], whereas stimulation at the rate of 5–10 Hz had the
opposite effect [Berardelli et al., 1998; Pascual-Leone et al.,
1994]. Furthermore, studies using rat hippocampal and
amygdale slice preparation demonstrated that in vitro elec-
trical stimulation using low-frequency rate induces long-
term depression of neurons under some conditions,
whereas acute high-frequency stimulation induced long-
term potentiation [Li et al., 1998; Malenka, 1994]. Recent
studies using functional MRI combined with simultaneous
scalp EEG recording have suggested that interictal epilepti-
form activity was frequently associated with subsequent
alteration of blood oxygenation level-dependent signals in
adults with focal epilepsy [Gotman et al., 2006; Kobayashi
et al., 2006]. These observations suggest that dynamic neu-
ronal activity may, in part, determine FDG PET patterns in
individuals with focal epilepsy.
On the other hand, morphological studies have sug-
gested that cortical hypometabolism in TSC may be due to
decreased numbers of neurons and abnormal dendritic
pattern in the cortical tubers, and that such abnormal neu-
rons with smaller membrane areas would require less
energy to maintain cellular membrane potentials [Hutten-
locher and Heydemann, 1984; Machado-Salas, 1984]. These
observations suggest that interictal baseline neuronal activ-
ity determined by the morphology of structural lesions
may also contribute to the hypometabolism seen on interic-
tal FDG PET.
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Methodological Considerations
The combined analysis of PET and quantitative intracra-
nial ECoG measures on an individual electrode basis was a
novel approach used in the present study. Yet, there were
several methodological limitations. First, although both PET
and ECoG studies for a given patient were obtained during
the interictal state, these were not obtained simultaneously.
Although a number of investigators have studied the rela-
tionship between PET and subdural ECoG measures in
patients with epilepsy [Asano et al., 2005; Henry et al., 1993;
Juhász et al., 2000; Luat et al., 2005; Olson et al., 1990], none
of the previous studies obtained simultaneous PET-ECoG
recordings. In the present study, we attempted to match the
conditions between the two series, as previously performed
in a study combining PET and 1H magnetic resonance spec-
troscopy [Pfund et al., 2000]. Patients who underwent PET
more than 12 months before ECoG recording were excluded
from the present study; none of the PET or ECoG data ana-
lyzed were derived from the postical state, and interictal
ECoG segments were selected according to the state (awake
or sleep) during the first 20 min of the FDG PET uptake pe-
riod. Yet, conditions between the two recordings almost cer-
tainly were different in the present study. Non-simultaneous
recordings may have led to the variance of PET imaging
pattern, which could not be explained by the multiple linear
regression model using the ECoG measures in the given
electrode site. In the present study, we determined whether
a longer interval between PET and ECoG studies was associ-
ated with a lower model fit in the regression equation in a
given subject, and the results suggested no statistically sig-
nificant association between the interval between PET and
ECoG studies and the degree of model fit represented by an
R-square value (supplementary Fig. S4).
The limitation of multiple regression analysis includes
‘‘collinearity among the predictor variables,’’ which can
potentially compromise the model [Cohen et al., 2002]. In
other words, failure to prove a statistically-significant corre-
lation between the PET fractional rank and ECoG amplitude
powers other than delta amplitude power does not necessar-
ily mean that ECoG components other than delta-wave did
not explain the variance of regional glucose metabolism on
PET at all. Since ECoG amplitude power at a frequency
band was certainly correlated to ECoG amplitude powers at
other frequency bands, it is possible that the predictive effect
of an ECoG amplitude power on PET measures may have
been eliminated by more dominant predictive effect of
ECoG amplitude power at another frequency band.
Factors which may affect PET and ECoG findings
include antiepileptic medications and intracranial electrode
placement. Previous scalp EEG and intracranial ECoG
studies in adults with focal epilepsy suggested that interic-
tal spike frequency was increased during the post-ictal pe-
riod but not simply after a decrease in medication
[Gotman and Koffler, 1989; Gotman and Marciani, 1985]. It
has been reported that cerebral metabolic rates for glucose
are globally decreased by several antiepileptic drugs [Spa-
naki et al., 1999; Theodore, 1988]. However, use of multi-
ple regression approach with glucose metabolism as an
outcome variable rescaled into six fractional units elimi-
nated such global effects of these medications on PET.
Therefore, the effects of antiepileptic drugs on FDG PET
studies are considered to be relatively small in the present
study.
It has also been reported that placement of intracranial
electrodes increases intracranial pressure (ICP) in patients
with focal epilepsy [Shah et al., 2007]. A previous [15O]-
water PET study of children with hydrocephalus reported
that increased ICP was associated with global decrease in
cerebral blood flow [Klinge et al., 1998]. Again, use of a
multiple regression approach eliminated such global
effects of pressure on ECoG measures.
Previous studies of adults with temporal lobe epilepsy
using PET and EEG applied an asymmetry index
approach to determine PET abnormalities [Erbayat Altay
et al., 2005; Koutroumanidis et al., 1998]. In other
words, PET abnormalities in the lateral temporal cortex
were determined by comparing its regional glucose
metabolism to that in the contralateral homotopic area,
which was assumed to have normal glucose metabolism.
This asymmetry index approach was not used in the
present study of TSC because an assumption of normal
glucose metabolism in the contralateral hemisphere was
not tenable.
Future Direction
In the present study, ECoG was recorded with a sam-
pling frequency of 200 Hz as previously described [Asano
et al., 2005]; we were not able to analyze ECoG activities
above Nyquist frequency, which was 100 Hz in the present
study. Thus, the logical next step in the research of interic-
tal FDG PET and ECoG relationships would be to analyze
ECoG data recorded with higher sampling frequency to
determine how gamma activities above 100 Hz can explain
the variance of metabolism pattern on FDG PET. Particu-
larly, gamma activities in area close to glucose hypometab-
olism may facilitate our understanding of the mechanism
of interictal and ictal discharges.
A longitudinal study on the same individuals with focal
epilepsy as well as a study of patients with etiologies other
than TSC (such as non-lesional focal epilepsy) may also
increase our understanding of the relationship between
interictal neuronal activity and glucose metabolism and
potentially elucidate the pathophysiology of interictal
hypermetabolism on FDG PET. Finally, we plan to apply
quantitative interictal PET and ECoG analysis for pediatric
epilepsy surgery subjects, to formulate a model for predic-
tion of surgical outcome.
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